Related Experiment Videos

In vitro effect of a mucolytic thiol agent on the activity of polymorphonuclear leucocyte elastase and

Thorax
|November 1, 1986
PubMed

Insights

Mercapto-ethanesulphonate (mesna), a mucolytic thiol agent, inhibits polymorphonuclear leucocyte (PMN) elastase and affects antileucoprotease activity. These actions may alter the proteinase-antiproteinase balance in airways when mesna is administered locally.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Respiratory Medicine

Background:

  • Polymorphonuclear leucocyte (PMN) elastase is implicated in airway inflammation and tissue damage.
  • Antileucoprotease is a key inhibitor of PMN elastase, maintaining proteinase-antiproteinase balance.
  • Mucolytic agents like mercapto-ethanesulphonate (mesna) are used to treat respiratory conditions.

Purpose of the Study:

  • To investigate the in vitro effects of mesna on PMN elastase activity.
  • To determine mesna's impact on antileucoprotease function.
  • To understand how mesna influences the proteinase-antiproteinase balance in airways.

Main Methods:

  • Enzyme activity assays using specific synthetic substrates to measure elastase activity.
  • Incubation of PMN elastase and antileucoprotease with varying concentrations of mesna.
  • Inhibition studies with iodoacetamide to probe the mechanism of mesna's effect on antileucoprotease.

Main Results:

  • Mesna non-competitively inhibited PMN elastase activity in a dose-dependent manner.
  • Mesna reduced elastase inhibitory activity of antileucoprotease in a concentration-dependent manner.
  • Mesna did not cause the release of active PMN elastase from its complex with antileucoprotease.

Conclusions:

  • Mesna directly inhibits PMN elastase activity.
  • Mesna modulates the inhibitory capacity of antileucoprotease.
  • Local administration of mesna may influence the proteinase-antiproteinase balance in airways.

Related Concept Videos